Patents Assigned to Fidelity Systems, Inc.
  • Patent number: 6747142
    Abstract: Compounds and the synthesis of compounds containing multiple precursor groups and allowing the efficient synthesis of highly functionalized oligonucleotides and oligomers are provided. Also, a branching unit that helps to further increase the density of functional groups on synthetic oligonucleotides and oligomers is provided.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: June 8, 2004
    Assignee: Fidelity Systems, Inc.
    Inventor: Nikolai N. Polouchine
  • Patent number: 6548251
    Abstract: A method of inhibiting at least one molecular process in a sample, comprising administering to the sample an oligonucleotide or polynucleotide containing at least one monomeric unit having formula (I): A—Xn  (I) wherein A is an organic moiety, n is at least 1, and each X is independently selected from the group consisting of —NRCOCONu, —NHCOCR2CR2CONu, —NHCOCR═CRCONu, and —NHCOSSCONu, wherein each R independently represents H or a substituted or unsubstituted alkyl group, and Nu represents a nucleophile, or a salt of the compound.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: April 15, 2003
    Assignee: Fidelity Systems, Inc.
    Inventors: Sergei A. Kozyavkin, Andrei G. Malykh, Nikolai N. Polouchine, Alexei I. Slesarev
  • Patent number: 5902879
    Abstract: Moieties, including a 2'-methoxyoxalamido and N-succinimido moieties, were incorporated into a compound, particularly an oligonucleotide molecule. The moieties were shown to be useful precursors for the post synthetic introduction of various functional additives.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: May 11, 1999
    Assignee: Fidelity Systems, Inc.
    Inventor: Nikolai N. Polouchine
  • Patent number: 5656463
    Abstract: A type 1 topoisomerase, designated topoisomerase V, has been isolated and substantially purified from the halophilic thermophilic methanogen bacterium Methanopyrus kandleri. The topoisomerase was purified by a process including the steps of lysing cells of M. kandleri to form a lysate, treating the lysate with polyethyleneimine to form a precipitate and a supernatant, precipitating the polyethyleneimine supernatant with ammonium sulfate, chromatographing the ammonium sulfate precipitate on phosphocellulose to produce a phosphocellulose eluate, chromatographing the phosphocellulose eluate on heparin to produce a heparin eluate, and chromatographing the heparin eluate on a column capable separating proteins by molecular size therein to produce a substantially purified thermostable DNA topoisomerase V. Topoisomerase V can relax DNA and can unlink DNA by reducing the linking number of closed circular DNA.
    Type: Grant
    Filed: December 30, 1994
    Date of Patent: August 12, 1997
    Assignee: Fidelity Systems, Inc.
    Inventor: Alexei I. Slesarev